Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2474
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis ; volume:17 ; number:1 ; day:14 ; month:6 ; year:2016 ; pages:1-11 ; date:12.2016
BMC musculoskeletal disorders ; 17, Heft 1 (14.6.2016), 1-11, 12.2016
- Urheber
-
Palmer, Jacqueline B.
- Beteiligte Personen und Organisationen
-
Li, Yunfeng
Herrera, Vivian
Liao, Minlei
Tran, Melody
Ozturk, Zafer E.
SpringerLink (Online service)
- DOI
-
10.1186/s12891-016-1102-z
- URN
-
urn:nbn:de:1111-201606171760
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Palmer, Jacqueline B.
- Li, Yunfeng
- Herrera, Vivian
- Liao, Minlei
- Tran, Melody
- Ozturk, Zafer E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Economic impact of biologic utilization patterns in patients with psoriatic arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
TCD4pos lymphocytosis in rheumatoid and psoriatic arthritis patients following TNFα blocking agents
Treatment patterns in psoriatic arthritis patients newly initiated on oral nonbiologic or biologic disease-modifying antirheumatic drugs
Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland
Treatment recommendations for psoriatic arthritis
Macrophage dysfunction in Psoriatic Arthritis
Lupus hands mimicking psoriatic arthritis
Economic Burden of Switching to Different Biologic Therapies Among Tumor Necrosis Factor Inhibitor-Experienced Patients with Psoriatic Arthritis
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Economic impact of biologic utilization patterns in patients with psoriatic arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
TCD4pos lymphocytosis in rheumatoid and psoriatic arthritis patients following TNFα blocking agents
Treatment patterns in psoriatic arthritis patients newly initiated on oral nonbiologic or biologic disease-modifying antirheumatic drugs
Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland
Treatment recommendations for psoriatic arthritis
Macrophage dysfunction in Psoriatic Arthritis
Lupus hands mimicking psoriatic arthritis
Economic Burden of Switching to Different Biologic Therapies Among Tumor Necrosis Factor Inhibitor-Experienced Patients with Psoriatic Arthritis
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Economic impact of biologic utilization patterns in patients with psoriatic arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
TCD4pos lymphocytosis in rheumatoid and psoriatic arthritis patients following TNFα blocking agents
Treatment patterns in psoriatic arthritis patients newly initiated on oral nonbiologic or biologic disease-modifying antirheumatic drugs
Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland
Treatment recommendations for psoriatic arthritis
Macrophage dysfunction in Psoriatic Arthritis
Lupus hands mimicking psoriatic arthritis